The A53T Parkinson’s Disease Mouse Model Shows Abnormal Outer Retinal OCT Metabolic Biomarker Patterns
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.12.28 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Ehimenmen S Ataman and 11 co-authors. Institution: Department of Ophthalmology, Visual, and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan, United States. Major MEDLINE topics: Tomography, Optical Coherence, Parkinson Disease, Retinal Pigment Epithelium, alpha-Synuclein. 71 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS, NIA NIH HHS.
Abstract (original language)
Purpose
The purpose of this study was to test for abnormal optical coherence tomography (OCT) metabolic biomarker patterns in the A53T Parkinson's disease model, which accumulates α-synuclein in photoreceptor inner segments before overt motor symptoms.
Methods
Four-to-6-month-old transgenic A53T homozygous mice and B6C3H wild-type (WT) littermate controls were evaluated using 2 OCT metabolic biomarkers. The first was the external limiting membrane (ELM) to retinal pigment epithelium (RPE) thickness, a proxy for subretinal space acidification and retinoid deficiency. The second biomarker was the sub-ELM hyper-reflective band profile shape minor:major aspect ratio, a proxy for mitochondrial configuration within photoreceptor inner segments. We also tested for outer nuclear layer (ONL) thinning, OCT metabolic biomarker sensitivity to light-dark conditions, and nicotinamide nucleotide transhydrogenase (Nnt) expression.
Results
A53T mice showed inferior and superior subnormal ELM-RPE thickness, and a supranormal sub-ELM hyper-reflective band profile shape aspect ratio in the inferior but not the superior retina. Central retinal ONL thickness was unremarkable between groups. Compared to light, dark-adaptation evoked contraction in ELM-RPE thickness and an increase in sub-ELM hyper-reflective band profile shape aspect ratio in both cohorts. In addition, B6C3H control mice expressed functional Nnt.
Conclusions
The abnormal OCT metabolic biomarker patterns raise the possibility of central outer retinal dysmetabolism in A53T mice, despite normal ONL thickness. Light-dark results show that ELM-RPE contraction can be caused by increased metabolic demand in the A53T mouse model.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology, Visual, and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan, United States.
- Department of Optometry and Vision Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
- Center for Biostatistics, Informatics and Data Science, MedStar Health Research Institute, Columbia, Maryland, United States.
Funding
- NEI NIH HHS
- NIA NIH HHS
Cite
APA
Ataman, E. S., Nguyen, C. T. O., Finkelstein, D. I., Wong, V. H. Y., Hoang, A., Lee, P. Y., Soetedjo, J., Klopp, B., Landowski, M., Podolsky, R. H., Roberts, R., & Berkowitz, B. A. (2026). The A53T Parkinson’s Disease Mouse Model Shows Abnormal Outer Retinal OCT Metabolic Biomarker Patterns. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.12.28
Vancouver
Ataman ES, Nguyen CTO, Finkelstein DI, Wong VHY, Hoang A, Lee PY, et al. The A53T Parkinson’s Disease Mouse Model Shows Abnormal Outer Retinal OCT Metabolic Biomarker Patterns. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.12.28
BibTeX
@article{Ataman2026,
author = {Ataman, Ehimenmen S and Nguyen, Christine T O and Finkelstein, David I and Wong, Vickie H Y and Hoang, Anh and Lee, Pei Ying and Soetedjo, James and Klopp, Brianna and Landowski, Michael and Podolsky, Robert H and Roberts, Robin and Berkowitz, Bruce A},
title = {The A53T Parkinson’s Disease Mouse Model Shows Abnormal Outer Retinal OCT Metabolic Biomarker Patterns},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.12.28}
}
EUVIMED